Epidemiological profile of patients with prostate adenocarcinoma in the western mesoregion of Rio Grande do Norte, Brazil
DOI:
https://doi.org/10.47456/rbps.v27i1.50756Keywords:
Epidemiology, Health Profile, Prostatic Neoplasms, Men's HealthAbstract
Introduction: Prostate cancer (PC) is the second most common malignant disease in men worldwide and, in Brazil, the most common, excluding non-melanoma skin cancer. Objective: To analyze the epidemiological profile of patients with prostate adenocarcinoma in the Western Mesoregion of Rio Grande do Norte. Methods: A retrospective study analyzed 737 medical records of patients with prostate adenocarcinoma between 2010 and 2019, considering data such as city, residence, age, ethnicity, marital status, education, and profession. Data were processed in Excel® 2021, analyzed in IBM® SPSS® Statistics 29, and visualized in QGIS® 3.34.5. Results: A higher incidence of PC was observed between 2015 and 2018, especially in 2018 (18.6%; n = 137). Most patients lived in urban areas (78.6%; n = 579), were married (67.3%; n = 496), and had a mean age of 79 years; 71.2% (n = 525) were between 70 and 89 years old. More than half self-declared as white (50.5%; n = 372) and 5.2% (n = 38) declared themselves black, which diverges from the literature. Regarding education, 25.9% (n = 191) had incomplete primary education and 12.2% (n = 90) had no schooling. Professionally, retirees (33.2%; n = 245) and farmers (23.6%; n = 174) predominated. Conclusion: The study revealed a discrepancy in the ethnic profile of patients compared to the literature, in which there is a higher incidence of PC among black men. Further research is recommended to understand the quality of life and factors associated with the prevalence of white patients with prostate adenocarcinoma.
Downloads
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3(4):524-548.
Instituto Nacional de Câncer (Brasil). Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2019 [citado 2024 jun 25]. Disponível em: https://www.inca.gov.br/numeros-de-cancer
Gonçalves-Silva AC, Murta-Nascimento C, Eluf-Neto J. Assessing screening practices among health care workers at a tertiary-care hospital in São Paulo, Brazil. Clinics. 2010;65(2):151-155.
Fuentes E, Fuentes F, Vilahur G, Badimon L, Palomo I. Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators Inflamm. 2013;2013:136584.
Pernar CH, Ebot EM, Wilson KM, Mucci LA. The epidemiology of prostate cancer. Cold Spring Harb Perspect Med. 2018;8(12):a030361.
Jahn JL, Giovannucci EL, Stampfer MJ. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era. Int J Cancer. 2015;137(12):2795-2802.
Ribeiro D. O povo brasileiro: formação e sentido. São Paulo: Companhia das Letras; 1995.
Lima-Costa MF, Barreto SM. Tipos de estudos epidemiológicos: conceitos básicos e aplicações na área do envelhecimento. Epidemiol Serv Saúde. 2003;12(4):189-201.
Santos CMC, Pimenta CAM, Nobre MRC. The PICO strategy for the research question construction and evidence search. Rev Latino-Am Enfermagem. 2007;15(3):508-511.
Tourinho-Barbosa RR, Pompeo AC, Glina S. Câncer de próstata no Brasil e na América Latina: epidemiologia e rastreamento. Int Braz J Urol. 2016;42(6):1081-1090.
Instituto Nacional de Câncer (Brasil). Estimativa 2023: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2022. 160 p.
Instituto Brasileiro de Geografia e Estatística. Sudeste concentra mais de um terço das áreas urbanizadas do país. Agência de Notícias IBGE [Internet]. 2023 jun 23 [citado 2024 jun 13]. Disponível em: https://agenciadenoticias.ibge.gov.br
Ascari RA, Pelissari S, Schmitt MD, Silva OM, Buss E, Ascari TM. Prevalência de exames diagnósticos de câncer de próstata em comunidade rural. Cogitare Enferm. 2014;19(1):133-140.
Bell KJL, Del Mar C, Wright G, Dickinson J, Glasziou P. Prevalence of incidental prostate cancer: a systematic review of autopsy studies. Int J Cancer. 2015;137(7):1749-1757.
Gonçalves IR, Padovani C, Popim RC. Caracterização epidemiológica e demográfica de homens com câncer de próstata. Ciênc Saúde Coletiva. 2008;13(4):1337-1342.
Lemos AP, Ribeiro C, Fernandes JG, Bernardes KA, Fernandes RT. Men's health: the reasons for men to reach out to health services. Rev Enferm UFPE On Line. 2017;11(Supl 11):4546-4553.
Korin D. Nuevas perspectivas de género en salud. Adolesc Latinoam. 2001;2(2):67-79.
Santos FS, Hamester J, Mikolaiczyk N, Reznicek SE, Noronha JAP. Câncer de próstata: uma breve revisão atualizada. Acta Méd (Porto Alegre). 2017;38(2):1-7.
Klein EA, Platz EA, Thompson IM. Epidemiology, etiology and prevention of prostate cancer. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 2704-2725.
Cooperberg MR, Presti Jr JC, Shinohara K, Carroll PR. Neoplasms of the prostate gland. In: McAninch JW, Lue TF, editors. Smith and Tanagho's general urology. 18th ed. New York: McGraw Hill; 2013. p. 350-379.
Darves-Bornoz A, Park J, Katz A. Prostate cancer epidemiology. In: Tewari AK, Whelan P, Graham JD, editors. Prostate cancer: diagnosis and clinical management. Chichester: Wiley Blackwell; 2014. p. 1-15.
Faria LSP, Pereira PC, Lustosa ALM, Aragão ICS, Aragão FMS, Cunha MGS. Perfil epidemiológico do câncer de próstata no Brasil: retrato de uma década. Rev Uningá. 2020;57(4):76-84.
Romero FR, Romero AW, Almeida RMS, Oliveira Jr FC, Tambara Filho R. The significance of biological, environmental, and social risk factors for prostate cancer in a cohort study in Brazil. Int Braz J Urol. 2012;38(6):769-778.
Romero FR, Romero AW, Almeida RMS, Tambara Filho R. The prevalence of prostate cancer in Brazil is higher in Black men than in White men: systematic review and meta-analysis. Int Braz J Urol. 2012;38(4):440-447.
Romero FR, Xavier LRTP, Romero AW, Almeida RMS, Matias JEF, Tambara Filho R. Heterogeneous methodology of racial/ethnic classification may be responsible for the different risk assessments for prostate cancer between Black and White men in Brazil. Int Braz J Urol. 2015;41(2):360-366.
Sociedade Brasileira de Urologia. Novembro Azul orienta sobre o câncer de próstata. Portal da Urologia [Internet]. 2018 out 11 [citado 2024 ago 14]. Disponível em: https://www.portaldaurologia.org.br
Tobias-Machado M, Carvalhal GF, Freitas Jr CH, Reis RB, Reis LO, Nogueira L, et al. Association between literacy, compliance with prostate cancer screening, and cancer aggressiveness: results from a Brazilian screening study. Int Braz J Urol. 2013;39(3):328-334.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Câncer de próstata relacionado ao trabalho. Rio de Janeiro: INCA; 2023 [citado 2024 jun 13]. Disponível em: https://ninho.inca.gov.br
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Thiago Gurgel Regis, João Lucas Filgueira Nogueira, Liliany Mirelly Bezerra Alves, Álvaro Marcos Pereira Lima, Tassio Danilo Rego de Queiroz, Éddio Dantas do Nascimento, Eudes Euler de Souza Lucena
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
